Tests:CA 125: Difference between revisions

Tests:CA 125
corrected sample types etc
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 34: Line 34:
|Specimen  
|Specimen  
|Serum
|Serum
Plasma
|-
|-
|Preferred
|Preferred
Line 73: Line 72:
|-
|-
|Test Method
|Test Method
|Abbott Alinity CI analyser using Abbott reagents.    
|Abbott Alinity i series analyser using Abbott reagents.  Chemiluminescent microparticle immunoassay.
 
CMIA method
|-
|-
|Advanced Notice
|Advanced Notice
Line 90: Line 87:
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}
<!-- review-ping: 2026-09-14T07:57:57.920Z -->